BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26458445)

  • 1. [Recent advancements in molecular cytogenetics for hematological malignancies: identification of novel PVT1 fusion genes].
    Taniwaki M
    Rinsho Ketsueki; 2015 Oct; 56(10):2056-65. PubMed ID: 26458445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
    Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
    Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia.
    Chinen Y; Sakamoto N; Nagoshi H; Taki T; Maegawa S; Tatekawa S; Tsukamoto T; Mizutani S; Shimura Y; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
    J Hematol Oncol; 2014 Sep; 7():68. PubMed ID: 25245984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA PVT1 and cancer.
    Cui M; You L; Ren X; Zhao W; Liao Q; Zhao Y
    Biochem Biophys Res Commun; 2016 Feb; 471(1):10-4. PubMed ID: 26850852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PVT1: A long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts.
    Tolomeo D; Agostini A; Visci G; Traversa D; Storlazzi CT
    Gene; 2021 May; 779():145497. PubMed ID: 33600954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.
    Ghetti M; Vannini I; Storlazzi CT; Martinelli G; Simonetti G
    Mol Cancer; 2020 Mar; 19(1):69. PubMed ID: 32228602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression Analysis of PVT1, CCDC26, and CCAT1 Long Noncoding RNAs in Acute Myeloid Leukemia Patients.
    Izadifard M; Pashaiefar H; Yaghmaie M; Montazeri M; Sadraie M; Momeny M; Jalili M; Ahmadvand M; Ghaffari SH; Mohammadi S; Alimoghaddam K; Ghavamzadeh A
    Genet Test Mol Biomarkers; 2018 Oct; 22(10):593-598. PubMed ID: 30222365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization.
    Kamath A; Tara H; Xiang B; Bajaj R; He W; Li P
    Cancer Genet Cytogenet; 2008 Jun; 183(2):117-20. PubMed ID: 18503831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
    Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential combination of karyotyping and RNA-sequencing in the search for cancer-specific fusion genes.
    Panagopoulos I; Thorsen J; Gorunova L; Micci F; Heim S
    Int J Biochem Cell Biol; 2014 Aug; 53():462-5. PubMed ID: 24863361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakpoint differentiation in chromosomal aberrations of hematological malignancies: Identification of 33 previously unrecorded breakpoints.
    Heller A; Loncarevic IF; Glaser M; Gebhart E; Trautmann U; Claussen U; Liehr T
    Int J Oncol; 2004 Jan; 24(1):127-36. PubMed ID: 14654949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
    Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
    Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies.
    Houshmand M; Yazdi N; Kazemi A; Atashi A; Hamidieh AA; Anjam Najemdini A; Mohammadi Pour M; Nikougoftar Zarif M
    Int J Biochem Cell Biol; 2018 May; 98():54-64. PubMed ID: 29510227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
    Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
    Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia.
    Tosi S; Ballabio E; Teigler-Schlegel A; Boultwood J; Bruch J; Harbott J
    Genes Chromosomes Cancer; 2005 Nov; 44(3):225-32. PubMed ID: 16028218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel fusion genes with 28S ribosomal DNA in hematologic malignancies.
    Kobayashi S; Taki T; Nagoshi H; Chinen Y; Yokokawa Y; Kanegane H; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
    Int J Oncol; 2014 Apr; 44(4):1193-8. PubMed ID: 24504345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PVT1: a rising star among oncogenic long noncoding RNAs.
    Colombo T; Farina L; Macino G; Paci P
    Biomed Res Int; 2015; 2015():304208. PubMed ID: 25883951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
    Skonieczka K; Matiakowska K; Haus O
    Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location and function of critical genes in leukemogenesis inferred from cytogenetic abnormalities in hematologic malignancies.
    Bernard OA; Berger R
    Semin Hematol; 2000 Oct; 37(4):412-9. PubMed ID: 11071362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.